z-logo
open-access-imgOpen Access
Phase I Drug Combination Trial Design: Walking the Tightrope
Author(s) -
Paul Hamberg,
Jaap Verweij
Publication year - 2009
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2009.23.6703
Subject(s) - medicine , cetuximab , clinical trial , docetaxel , drug , clinical study design , drug development , modalities , oncology , surrogate endpoint , intensive care medicine , cancer , medical physics , pharmacology , colorectal cancer , social science , sociology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom